Ezt az oldalt automatikusan lefordították, és a fordítás pontossága nem garantált. Kérjük, olvassa el a angol verzió forrásszöveghez.

Effects of Lung Recruitment on Cerebral Hemodynamics(LRCH)

2026. november 18. frissítette: Xingui Dai, First People's Hospital of Chenzhou

Effects of Lung Recruitment on Cerebral Hemodynamics: a Single-center, Prospective, Randomized-order, Three-period, Self-controlled Design Trial

Patients receiving invasive mechanical ventilation may develop alveolar derecruitment due to atelectasis, secretion retention, changes in body position, or acute respiratory distress syndrome. Lung recruitment maneuvers reopen partially collapsed alveoli by briefly increasing transpulmonary pressure, thereby improving lung volume and oxygenation; however, elevated airway pressure may also affect venous return, mean arterial pressure, and carbon dioxide elimination, and thus alter cerebral blood flow. Therefore, improved oxygenation does not necessarily indicate stable cerebral circulation.

At present, when selecting a lung recruitment modality in clinical practice, clinicians often rely on oxygenation response, respiratory mechanics, and operator experience, while dynamic observation of cerebral hemodynamics remains relatively insufficient. Recording only two time points before and after the maneuver may miss transient but clinically meaningful changes during pressurization, maintenance of high pressure, and recovery. Therefore, under controlled and safe conditions, it is necessary to use three commonly used clinical lung recruitment maneuvers as observational scenarios to describe cerebral hemodynamic changes during lung recruitment and to explore possible physiological factors in conjunction with cardiac output, systemic blood pressure, carbon dioxide, and respiratory mechanics. The findings are expected to provide a physiological basis for bedside cerebral perfusion monitoring and risk identification; however, short-term changes in Vm alone cannot prove that a particular maneuver is safer or improves long-term outcomes.

A tanulmány áttekintése

Tanulmány típusa

Beavatkozó

Beiratkozás (Becsült)

40

Fázis

  • Nem alkalmazható

Kapcsolatok és helyek

Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.

Tanulmányi kapcsolat

Részvételi kritériumok

A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.

Jogosultsági kritériumok

Tanulmányozható életkorok

18 év (Felnőtt, Idősebb felnőtt)

Egészséges önkénteseket fogad

Nem

Tanulmányozható nemek

Összes

Leírás

Inclusion Criteria:

  • (1)Age 18 years or older.
  • (2)Receiving invasive mechanical ventilation through an endotracheal tube or tracheostomy.
  • (3)A clinical indication for a lung recruitment maneuver, with an expectation that three bedside observation periods can be completed during hospitalization.
  • (4)An adequate temporal acoustic window for reproducible transcranial Doppler recordings and an adequate echocardiographic window for reproducible left ventricular outflow tract velocity-time integral measurements.
  • (5)Axillary temperature between 36.0°C and 37.3°C.
  • (6)Written informed consent provided by the participant or a legally authorized representative.

Exclusion Criteria:

  • (1)Current use of vasoactive medications.
  • (2)Known severe cardiac dysfunction or severe pulmonary hypertension.
  • (3)Undrained pneumothorax, marked airflow limitation, giant pulmonary bullae, or another condition associated with a high risk of barotrauma.
  • (4)Known markedly elevated intracranial pressure or escalating treatment for intracranial hypertension.
  • (5)Any other condition that, in the investigator's judgment, makes participation inappropriate.

Tanulási terv

Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.

Hogyan készül a tanulmány?

Tervezési részletek

  • Elsődleges cél: Egyéb
  • Kiosztás: Véletlenszerűsített
  • Beavatkozó modell: Crossover kiosztás
  • Maszkolás: Nincs (Open Label)

Fegyverek és beavatkozások

Résztvevő csoport / kar
Beavatkozás / kezelés
Kísérleti: Sequence 1: A-B-C

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Kísérleti: Sequence 2: B-C-A

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Kísérleti: Sequence 3: C-A-B

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Kísérleti: Sequence 1: A-C-B

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Kísérleti: Sequence 1: B-A-C

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Kísérleti: Sequence 1: C-B-A

A researcher who is not involved in outcome assessment will generate the randomized sequence. The three lung recruitment maneuvers will be designated A, B, and C and assigned in one of six sequences: ABC, ACB, BAC, BCA, CAB, or CBA. Consecutive observation periods will be separated by at least 12 hours. Before each period, the clinical indication for lung recruitment and the stability of vital signs will be reassessed, and the patient's position and sedation regimen will be confirmed to have remained substantially unchanged. If these conditions are not met, the period will be postponed or canceled. Any study withdrawal or early termination of a maneuver will be documented as specified above; newly enrolled participants must not be used to replace such events without reporting them.

Before method A, original ventilator settings are kept stable for at least 10 minutes. Baseline ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) are recorded. Pressure-controlled ventilation is used with inspiratory driving pressure <=15 cmH2O, respiratory rate 16/min, I:E=1:2, and unchanged fraction of inspired oxygen (FiO2). Starting at baseline positive end-expiratory pressure (PEEP), PEEP rises by 5 cmH2O every 60 seconds to a maximum of 20 cmH2O (a smaller final increment is allowed). The same variables are recorded in the last 10 seconds of each step. After 60 seconds at PEEP 20, PEEP falls by 3 cmH2O every 60 seconds to baseline (the final decrement may vary), with measurements in each step's last 10 seconds. Original ventilator settings are restored, and measurements are repeated 60 seconds later.

Before method B, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded at baseline. The ventilator will then be switched to continuous positive airway pressure (CPAP) mode, applying a constant airway pressure of 25 cmH2O for 40 seconds. The same measurements will be obtained during seconds 35-40 of the maneuver. At 40 seconds, the original clinical ventilator settings will be restored immediately. The same measurements will be repeated 40 seconds after restoration as recovery measurements.

Before method C, the patient's original clinical ventilator settings will be maintained for at least 10 minutes to establish a stable baseline. Ventilator parameters, vital signs, end-tidal carbon dioxide (EtCO2), transcranial Doppler ultrasonography (TCD) parameters, and left ventricular outflow tract velocity-time integral (LVOT-VTI) will be recorded as the first set of measurements at baseline. Pressure-controlled ventilation will then be applied with positive end-expiratory pressure (PEEP) of 20 cmH2O, a set inspiratory driving pressure of no more than 15 cmH2O, a respiratory rate of 16 breaths/min, and an inspiratory-to-expiratory ratio of 1:2 for 120 seconds. The second set of the same measurements will be obtained near the end of the 120-second maneuver. The patient's original clinical ventilator settings will then be restored immediately. The third set of measurements will be obtained 60 seconds after restoration.

Mit mér a tanulmány?

Elsődleges eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
mean flow velocity in the middle cerebral artery
Időkeret: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Middle cerebral artery mean flow velocity (Vm, cm/s) will be measured using transcranial Doppler ultrasonography (TCD). In each study period, measurements will be obtained after at least 10 minutes of stable baseline ventilation. For method A, measurements will be obtained during the final 10 seconds of each 60-second PEEP step and 60 seconds after return to the original ventilation settings. For method B, measurements will be obtained at 35-40 seconds of sustained inflation and 40 seconds after return to the original settings. For method C, measurements will be obtained at baseline and 60 seconds after return to the original settings following the 120-second maneuver. No intra-maneuver TCD measurement is scheduled for method C.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Másodlagos eredményintézkedések

Eredménymérő
Intézkedés leírása
Időkeret
Systolic blood flow velocity (Vs) of the middle cerebral artery
Időkeret: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The Systolic blood flow velocity (Vs) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
diastolic blood flow velocity (Vd) of the middle cerebral artery
Időkeret: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The diastolic blood flow velocity (Vd) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
pulsatility index (PI) of the middle cerebral artery
Időkeret: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The pulsatility index (PI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
resistance index(RI) of the middle cerebral artery
Időkeret: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

The resistance index(RI) of the middle cerebral artery will be measured by transcranial Doppler ultrasonography at the prespecified time points in each study period. The observed value and change from the period-specific baseline will be reported.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
Arterial partial pressure of carbon dioxide (PaCO2)
Időkeret: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

PaCO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial partial pressure of oxygen (PaO2)
Időkeret: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

PaO2 (mmHg) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial blood pH
Időkeret: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

Arterial blood pH will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Arterial blood lactate concentration
Időkeret: Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.

Arterial blood lactate concentration (mmol/L) will be measured by arterial blood gas analysis before and after each lung recruitment maneuver. The measured values and the change from the pre-maneuver value will be reported for each study period.

Before and after each lung recruitment maneuver in each of up to three study periods, with at least 12 hours between periods.
Left ventricular outflow tract velocity-time integral (LVOT-VTI)
Időkeret: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

LVOT-VTI (cm) will be measured by Doppler echocardiography at the same prespecified time points as transcranial Doppler measurements in each study period. The measured value and its change from the period-specific pre-maneuver baseline will be reported. For method C, measurements are scheduled only at baseline and during recovery, not during the 120-second maneuver.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.
End-tidal carbon dioxide (EtCO2)
Időkeret: 3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

EtCO2 (mmHg) will be monitored by capnography. A valid end-expiratory value will be recorded at the same prespecified time points as the TCD and LVOT-VTI measurements in each study period. The measured value and change from the period-specific baseline will be reported. If no valid expiratory waveform is available at a time point, the value will be recorded as missing.In the Time Frame, "return" refers to restoration of the patient's original clinical ventilator settings.

3 periods (at least 12 hours apart): baseline; method A, final 10 seconds at each 60-second PEEP level and 60 seconds after return; method B, 35-40 seconds and 40 seconds after return; method C, near 120 seconds and 60 seconds after return.

Együttműködők és nyomozók

Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.

Nyomozók

  • Tanulmányi szék: Xingui Dai PhD, PHD, Chen Zhou NO.1 People's Hospital

Tanulmányi rekorddátumok

Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.

Tanulmány főbb dátumok

Tanulmány kezdete (Becsült)

2026. november 1.

Elsődleges befejezés (Becsült)

2028. április 1.

A tanulmány befejezése (Becsült)

2028. május 1.

Tanulmányi regisztráció dátumai

Először benyújtva

2026. november 6.

Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak

2026. november 18.

Első közzététel (Tényleges)

2026. november 20.

Tanulmányi rekordok frissítései

Utolsó frissítés közzétéve (Tényleges)

2026. november 20.

Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak

2026. november 18.

Utolsó ellenőrzés

2026. november 1.

Több információ

A tanulmányhoz kapcsolódó kifejezések

Terv az egyéni résztvevői adatokhoz (IPD)

Tervezi megosztani az egyéni résztvevői adatokat (IPD)?

IGEN

IPD megosztási időkeret

Beginning 6 months after publication of the main study results and available for 3 years.

IPD-megosztási hozzáférési feltételek

Qualified researchers may submit a written request including research purpose, analysis plan, requested data elements, and data protection measures. Requests will be reviewed by the principal investigator and the institution.

Az IPD megosztását támogató információ típusa

  • STUDY_PROTOCOL

Gyógyszer- és eszközinformációk, tanulmányi dokumentumok

Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz

Nem

Egy amerikai FDA által szabályozott eszközterméket tanulmányoz

Nem

Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .

Iratkozz fel